{"transactions":[{"id":681809,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2026-08-19T21:00:01.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":1728,"price":7.52,"value":12994.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These American Depositary Shares represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs will vest in full on September 15, 2026."}],"balance_after":23309,"source":{"system":"sec-edgar","filing":"0001493152-26-039246","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315226039246/ownership.xml","form_type":"4"}},{"id":696048,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2026-08-05T22:30:02.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":1130,"price":11.5,"value":12995.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These American Depositary Shares represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs will vest in full on August 16, 2026."}],"balance_after":21581,"source":{"system":"sec-edgar","filing":"0001493152-26-036231","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315226036231/ownership.xml","form_type":"4"}},{"id":726723,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2026-06-26T00:06:51.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":13,"value":13000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These American Depositary Shares represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026."}],"balance_after":20452,"source":{"system":"sec-edgar","filing":"0001493152-26-030210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315226030210/ownership.xml","form_type":"4"}},{"id":726722,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2026-06-26T00:06:51.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":7353,"price":3.74,"value":27500.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These American Depositary Shares represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026."}],"balance_after":19452,"source":{"system":"sec-edgar","filing":"0001493152-26-030210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315226030210/ownership.xml","form_type":"4"}},{"id":726721,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2026-06-26T00:06:51.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":3725,"price":3.49,"value":13000.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These American Depositary Shares represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026."}],"balance_after":12099,"source":{"system":"sec-edgar","filing":"0001493152-26-030210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315226030210/ownership.xml","form_type":"4"}},{"id":726720,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2026-06-26T00:06:51.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":2539,"price":5.12,"value":12999.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These American Depositary Shares represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026."}],"balance_after":8374,"source":{"system":"sec-edgar","filing":"0001493152-26-030210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315226030210/ownership.xml","form_type":"4"}},{"id":726719,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2026-06-26T00:06:51.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":1570,"price":8.28,"value":12999.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These American Depositary Shares represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026."}],"balance_after":5835,"source":{"system":"sec-edgar","filing":"0001493152-26-030210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315226030210/ownership.xml","form_type":"4"}},{"id":726718,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2026-06-26T00:06:51.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":1395,"price":9.32,"value":13001.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These American Depositary Shares represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026."}],"balance_after":4265,"source":{"system":"sec-edgar","filing":"0001493152-26-030210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315226030210/ownership.xml","form_type":"4"}},{"id":726717,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2026-06-26T00:06:51.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":1248,"price":10.02,"value":12504.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These American Depositary Shares represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026."}],"balance_after":2870,"source":{"system":"sec-edgar","filing":"0001493152-26-030210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315226030210/ownership.xml","form_type":"4"}},{"id":942490,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T22:01:17.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"7,500 shares of the underlying options vest s on grant date and the remaining balance in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting."}],"balance_after":57500,"derivative":{"exercise_price":1.31,"expiration_date":"2031-01-05","underlying":"COMMON STOCK","underlying_shares":57500},"source":{"system":"sec-edgar","filing":"0001520138-26-000019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000152013826000019/ownership.xml","form_type":"4"}},{"id":963428,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Pre-Funded Warrants to purchase ADRs","published_at":"2025-12-19T02:57:09.000Z","date":"2025-12-16","kind":"purchase","planned":false,"acquired":true,"shares":24745,"price":0.4041,"value":9999.4545,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer."},{"field":"security","element":"securityTitle","label":"F2","text":"On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 24,745 ADSs (the \"PIPE PFWs\" and ) and (ii) accompanying Series G Warrants to purchase up to 24,745 ADSs (the \"Series G Warrants\"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Conversion Exercise Price of Security is $0.00001"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the Private Placement Unregistered Warrants remaining exercisable until fully exercised."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the Private Placement Unregistered Warrants remaining exercisable until fully exercised."}],"balance_after":24745,"derivative":{"exercise_price":0,"underlying":"American Depositary Shares representing Ordinary Shares","underlying_shares":24745},"source":{"system":"sec-edgar","filing":"0001493152-25-028419","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315225028419/ownership.xml","form_type":"4"}},{"id":963427,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Warrants to purchase American Depositary Shares (\"ADRs\")","published_at":"2025-12-19T02:57:09.000Z","date":"2025-12-16","kind":"purchase","planned":false,"acquired":true,"shares":24745,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer."},{"field":"security","element":"securityTitle","label":"F2","text":"On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 24,745 ADSs (the \"PIPE PFWs\" and ) and (ii) accompanying Series G Warrants to purchase up to 24,745 ADSs (the \"Series G Warrants\"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the Private Placement Unregistered Warrants remaining exercisable until fully exercised."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the Private Placement Unregistered Warrants remaining exercisable until fully exercised."}],"balance_after":24745,"derivative":{"exercise_price":0.3883,"underlying":"American Depositary Shares representing Ordinary Shares","underlying_shares":24745},"source":{"system":"sec-edgar","filing":"0001493152-25-028419","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315225028419/ownership.xml","form_type":"4"}},{"id":1008456,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2025-11-04T22:00:02.000Z","date":"2025-11-01","kind":"grant","planned":false,"acquired":true,"shares":26619,"price":0.75,"value":19964.25,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer"},{"field":"shares","element":"transactionShares","label":"F3","text":"These ADSs represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on February 15, 2026."}],"balance_after":26619,"source":{"system":"sec-edgar","filing":"0001493152-25-020753","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315225020753/ownership.xml","form_type":"4"}},{"id":1008455,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2025-11-04T22:00:02.000Z","date":"2025-11-01","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0.75,"value":24000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer"},{"field":"shares","element":"transactionShares","label":"F2","text":"These ADSs represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on January 1, 2026."}],"balance_after":32000,"source":{"system":"sec-edgar","filing":"0001493152-25-020753","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315225020753/ownership.xml","form_type":"4"}},{"id":1013911,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2025-10-24T13:18:57.000Z","date":"2025-10-22","kind":"grant","planned":false,"acquired":true,"shares":6277,"price":0.74,"value":4644.98,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer"},{"field":"shares","element":"transactionShares","label":"F2","text":"These ADSs represent restricted stock units (\"RSUs\"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on October 31, 2025."}],"balance_after":6277,"source":{"system":"sec-edgar","filing":"0001493152-25-019194","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000149315225019194/ownership.xml","form_type":"4"}}]}